The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Determinants of Abnormal Gonadotropin Secretion in Clinically Defined Women with Polycystic Ovary Syndrome1
Abstract
Polycystic ovary syndrome (PCOS) is a heterogeneous disorder of reproductive age women characterized in its broadest definition by the presence of oligoamenorrhea and hyperandrogenism and the absence of other disorders. Defects of gonadotropin secretion, including an elevated LH level, elevated LH to FSH ratio, and an increased frequency and amplitude of LH pulsations have been described, but the prevalence of these defects in a large, unbiased population of PCOS patients has not been determined. Sixty-one women with PCOS defined by oligomenorrhea and hyperandrogenism and 24 normal women in the early follicular phase had LH samples obtained every 10 min for 8–12 h. Pool LH levels from the frequent sampling studies were within the normal range in the 9 PCOS patients (14.8%) who were studied within 21 days after a documented spontaneous ovulation. Excluding these post-ovulatory patients, 75.0% of the PCOS patients had an elevated pool LH level (above the 95th percentile of the normal controls), and 94% had an elevated LH to FSH ratio. In the anovulatory PCOS patients, pool LH correlated positively with 17-OH progesterone (R = 0.30, P = 0.03), but not with estradiol, estrone, testosterone, androstenedione, or DHEA-S. Pool LH and LH to FSH ratio correlated positively with LH pulse frequency (R = 0.40, P = 0.004 for pool LH, and R = 0.39; P = 0.005 for LH/FSH). There was also a strong negative correlation between pool LH and body mass index (BMI) (R = −0.59, P < 10−5). The relationship between BMI and LH secretion in the PCOS patients appeared to be strongest with body fatness, as pool LH was correlated inversely with percent body fat, whether measured by skinfolds (R= −0.61, P < 10−5), bioimpedance (R = −0.55, P < 10−4), or dual energy x-ray absorptiometry (DEXA) (R = −0.70, P = 0.001; n = 18 for DEXA only). By DEXA, the only body region that was highly correlated with pool LH was the trunk (R = −0.71, P = 0.001). The relationship between body fatness and LH secretion occurred via a decrease in LH pulse amplitude (R = −0.63, P< 10−5 for BMI; R = −0.58, P < 10−4 for bioimpedance; and R = −0.64, P = 0.004 for whole body DEXA), with no significant change in pulse frequency with increasing obesity (R = −0.17, P = 0.23 for BMI). In conclusion: 1) the prevalence of gonadotropin abnormalities is very high in women with PCOS selected on purely clinical grounds, but is modified by recent spontaneous ovulation; 2) the positive relationship between LH pulse frequency and both pool LH and LH to FSH ratio supports the hypothesis that a rapid frequency of GnRH secretion may play a key etiologic role in the gonadotropin defect in PCOS patients; 3) pool LH and LH pulse amplitude are inversely related to body mass index and percent body fat in a continuous fashion; and 4) the occurrence of a continuous spectrum of gonadotropin abnormalities varying with body fat suggests that nonobese and obese patients with PCOS do not represent distinct pathophysiologic subsets of this disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Durnin, J. V. G. A., & Womersley, J. (1974) · British Journal of Nutrition · doi:10.1079/bjn19740060 · Cited by 6,343
CLINICAL ASSESSMENT OF BODY HAIR GROWTH IN WOMEN
FERRIMAN, D., & GALLWEY, J. D. (1961) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-21-11-1440 · Cited by 2,506
Amenorrhea associated with bilateral polycystic ovaries
Stein, I. F., & Leventhal, M. L. (1935) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(15)30642-6 · Cited by 2,121
Velazquez, E. M., Mendoza, S., Hamer, T., Sosa, F., & Glueck, C. J. (1994) · Metabolism · doi:10.1016/0026-0495(94)90209-7 · Cited by 865
Nestler, J. E., & Jakubowicz, D. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350902 · Cited by 743
REVIEW ARTICLE: THE POLYCYSTIC OVARY SYNDROME
YEN, S. S. C. (1980) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1980.tb02132.x · Cited by 698
Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
Rebar, R., Judd, H. L., Yen, S. S., Rakoff, J., Vandenberg, G., & Naftolin, F. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108400 · Cited by 622
DUNAIF, A., GRAF, M., MANDELI, J., LAUMAS, V., & DOBRJANSKY, A. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-65-3-499 · Cited by 586
Speiser, P. W., Dupont, J., Zhu, D., Serrat, J., Buegeleisen, M., Tusie-Luna, M. T., Lesser, M., New, M. I., & White, P. C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115897 · Cited by 572
Filicori, M., Butler, J. P., & Crowley, W. F. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111370 · Cited by 548
Research works printed but not linked: 4
- Vermes, 1991, Interpretations of five monoclonal immunoassays of lutropin and follitropin: effects of normalization with WHO standard., Clin Chim, 37, 415, 10.1093/clinchem/37.3.415 · doi:10.1093/clinchem/37.3.415
- Imse, 1992, Comparison of luteinizing hormone pulsatility in the serum of women suffering from polycystic ovarian disease using a bioassay and five different immunoassays., J Clin Endocrinol Metab, 74, 1053
- Wentz, 1976, Pulsatile gonadotropin output in menstrual dysfunction., Obstet Gynecol, 47, 309
- Pepperell, 1975, Studies on the metabolic clearance rate and production rate of human luteinizing hormone and on the initial half-time of its subunits in man., J Clin Invest, 56, 118, 10.1172/JCI108060 · doi:10.1172/jci108060
Cited by
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Witchel, S. F., Oberfield, S., Rosenfield, R. L., Codner, E., Bonny, A., Ibáñez, L., Pena, A., Horikawa, R., Gomez-Lobo, V., Joel, D., et al. (2015) · Hormone Research in Paediatrics · doi:10.1159/000375530 · Cited by 3,113
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132
Self-citationDiamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Rosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., & Azziz, R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.217 · Cited by 1,488
“which contributes to reduced serum LH levels with increased percent body adipose tissue”
BackgroundObesity and the polycystic ovary syndrome
Gambineri, A., Pelusi, C., Vicennati, V, Pagotto, U., & Pasquali, R. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0801994 · Cited by 836
The Insulin-Related Ovarian Regulatory System in Health and Disease
Poretsky, L., Cataldo, N. A., Rosenwaks, Z., & Giudice, L. C. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0374 · Cited by 818
Follicle dynamics and anovulation in polycystic ovary syndrome
Franks, S., Stark, J., & Hardy, K. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn015 · Cited by 581
Abbott, D. H., Barnett, D. K., Bruns, C. M., & Dumesic, D. A. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi013 · Cited by 555
Jonard, S. (2004) · Human Reproduction Update · doi:10.1093/humupd/dmh010 · Cited by 519
Developmental origin of polycystic ovary syndrome—a hypothesis
Abbott, D., Dumesic, D., & Franks, S. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1740001 · Cited by 504
“If, for example, LH levels are monitored regularly over a period of several weeks, tonically high serum LH concentrations may fall into the normal range if a spontaneous ovulatory cycle occurs (Franks 1989, Taylor et al. 1997).”
BackgroundIbáñez, L., Oberfield, S. E., Witchel, S., Auchus, R. J., Chang, R. J., Codner, E., Dabadghao, P., Darendeliler, F., Elbarbary, N. S., Gambineri, A., et al. (2017) · Hormone Research in Paediatrics · doi:10.1159/000479371 · Cited by 463
Cimino, I., Casoni, F., Liu, X., Messina, A., Parkash, J., Jamin, S. P., Catteau-Jonard, S., Collier, F., Baroncini, M., Dewailly, D., et al. (2016) · Nature Communications · doi:10.1038/ncomms10055 · Cited by 404
Animal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome
Stener-Victorin, E., Padmanabhan, V., Walters, K. A., Campbell, R. E., Benrick, A., Giacobini, P., Dumesic, D. A., & Abbott, D. H. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa010 · Cited by 348
Eagleson, C. A., Gingrich, M. B., Pastor, C. L., Arora, T. K., Burt, C. M., Evans, W. S., & Marshall, J. C. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.11.6992 · Cited by 345
GnRH Pulsatility, the Pituitary Response and Reproductive Dysfunction
TSUTSUMI, R., & WEBSTER, N. J. G. (2009) · Endocrine Journal · doi:10.1507/endocrj.k09e-185 · Cited by 317
The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome
Blank, S. K., McCartney, C. R., & Marshall, J. C. (2006) · Human Reproduction Update · doi:10.1093/humupd/dml017 · Cited by 301
Deconstructing a Syndrome: Genomic Insights Into PCOS Causal Mechanisms and Classification
Dapas, M., & Dunaif, A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac001 · Cited by 300
Identifying Children at Risk for Polycystic Ovary Syndrome
Rosenfield, R. L. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2012 · Cited by 288
Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome
De Leo, V., la Marca, A., & Petraglia, F. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0015 · Cited by 286
Pastor, C. L., Griffin-Korf, M. L., Aloi, J. A., Evans, W. S., & Marshall, J. C. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4604 · Cited by 263
Welt, C. K., Gudmundsson, J. A., Arason, G., Adams, J., Palsdottir, H., Gudlaugsdottir, G., Ingadottir, G., & Crowley, W. F. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1327 · Cited by 261
Self-citationLegro, R. S., Schlaff, W. D., Diamond, M. P., Coutifaris, C., Casson, P. R., Brzyski, R. G., Christman, G. M., Trussell, J. C., Krawetz, S. A., Snyder, P. J., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1123 · Cited by 213
van Hooff, M. H. A. (2004) · Human Reproduction · doi:10.1093/humrep/deh079 · Cited by 162
Xu, N., Kwon, S., Abbott, D. H., Geller, D. H., Dumesic, D. A., Azziz, R., Guo, X., & Goodarzi, M. O. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027286 · Cited by 155
Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause
Welt, C. K., & Carmina, E. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2375 · Cited by 148
Joffe, H., Cohen, L. S., Suppes, T., McLaughlin, W. L., Lavori, P., Adams, J. M., Hwang, C. H., Hall, J. E., & Sachs, G. S. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.10.017 · Cited by 134
Self-citationMcCartney, C. R., Prendergast, K. A., Blank, S. K., Helm, K. D., Chhabra, S., & Marshall, J. C. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1252 · Cited by 116
The Genetics of Obesity Lessons for Polycystic Ovary Syndrome
LEGRO, R. S. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06230.x · Cited by 109
Clinical spectrum of premature pubarche: Links to metabolic syndrome and ovarian hyperandrogenism
Ibáñez, L., Díaz, R., López-Bermejo, A., & Marcos, M. V. (2009) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-008-9096-y · Cited by 106
Polycystic Ovary Syndrome in Adolescence
Blank, S. K., Helm, K. D., McCartney, C. R., & Marshall, J. C. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1429.005 · Cited by 97
Kamenov, Z., & Gateva, A. (2020) · Molecules · doi:10.3390/molecules25235566 · Cited by 100
“Lean patients with PCOS, oligo-anovulation, and hyperandrogenemia can have normal insulin sensitivity, but more frequently have increased LH levels than those with obesity [45,58].”
BackgroundZhang, H. Y., Guo, C. X., Zhu, F. F., Qu, P. P., Lin, W. J., & Xiong, J. (2013) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-012-2568-z · Cited by 94
Kisspeptin and Polycystic Ovary Syndrome
Tang, R., Ding, X., & Zhu, J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00298 · Cited by 93
Coyle, C., & Campbell, R. E. (2019) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2019.110561 · Cited by 89
Rosenfield, R. L., Wroblewski, K., Padmanabhan, V., Littlejohn, E., Mortensen, M., & Ehrmann, D. A. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.03.059 · Cited by 80
Kawwass, J. F., Sanders, K. M., Loucks, T. L., Rohan, L. C., & Berga, S. L. (2017) · Human Reproduction · doi:10.1093/humrep/dex086 · Cited by 79
Moret, M., Stettler, R., Rodieux, F., Gaillard, R. C., Waeber, G., Wirthner, D., Giusti, V., Tappy, L., & Pralong, F. P. (2009) · Neuroendocrinology · doi:10.1159/000160911 · Cited by 72
Diagnosis of Polycystic Ovary Syndrome: AMH in combination with clinical symptoms
Sahmay, S., Aydin, Y., Oncul, M., & Senturk, L. M. (2014) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-013-0149-0 · Cited by 71
Reproductive neuroendocrine dysfunction in polycystic ovary syndrome: Insight from animal models
Roland, A. V., & Moenter, S. M. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.04.002 · Cited by 57
Joffe, H., Cohen, L. S., Suppes, T., Hwang, C. H., Molay, F., Adams, J. M., Sachs, G. S., & Hall, J. E. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.05.027 · Cited by 56
Self-citationvan Dam, E. W. C. M., Roelfsema, F., Veldhuis, J. D., Hogendoorn, S., Westenberg, J., Helmerhorst, F. M., Frölich, M., Krans, H. M. J., Meinders, A. E., & Pijl, H. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00377.2003 · Cited by 51
Ovarian and extra-ovarian mediators in the development of polycystic ovary syndrome
Puttabyatappa, M., & Padmanabhan, V. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0079 · Cited by 43
Graham, E. J., & Selgrade, J. F. (2017) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2017.01.007 · Cited by 25
Modeling Endocrine Control of the Pituitary–Ovarian Axis: Androgenic Influence and Chaotic Dynamics
Hendrix, A. O., Hughes, C. L., & Selgrade, J. F. (2014) · Bulletin of Mathematical Biology · doi:10.1007/s11538-013-9913-7 · Cited by 19
Plasma adrenomedullin levels in patients with polycystic ovary syndrome
Ucar, B., Noyan, V., Caglayan, O., Yucel, A., & Sagsoz, N. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.02.119 · Cited by 5
Metadata
- Authors
- Taylor, A. E., McCourt, B., Martin, K. A., Anderson, E. J., Adams, J. M., Schoenfeld, D., & Hall, J. E.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1997-07-01
- Volume
- 82
- Issue
- 7
- Pages
- 2248-2256
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1973015402
- Cited by
- 494
- References
- 57
- FWCI
- 11.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.